Management of hypertension in pregnancy

Clinical and Experimental Hypertension

Volumn 21, Issue 5-6, 1999, Pages 907-916

  Brown, Mark A ^a   Whitworth, Judith A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Eclampsia; Gestational hypertension; Hydralazine; Magnesium; Methyldopa; Oxprenolol; Placenta; Pre eclampsia; Volume expansion; White coat Hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CLONIDINE; DIAZEPAM; HYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; OXPRENOLOL; PHENYTOIN; PINDOLOL; PRAZOSIN;

CONFERENCE PAPER; ECLAMPSIA; ESSENTIAL HYPERTENSION; FEMALE; FETUS DEATH; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE GROWTH RETARDATION; INTRAVENOUS DRUG ADMINISTRATION; MATERNAL HYPERTENSION; ORAL DRUG ADMINISTRATION; PLACENTA CIRCULATION; PREECLAMPSIA; STROKE; SUBLINGUAL DRUG ADMINISTRATION; WHITE COAT HYPERTENSION;

EID: 0032802077     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909061019     Document Type: Conference Paper

References (47)

1. Halligan A, Shennan A, Thurston H, De Swiet M, Taylor D. Ambulatory blood pressure measurement in pregnancy: The current state of the art. Hypertens Pregnancy. 1995; 14: 1-16.
2. Brown MA, Reiter L, Smith B, Buddle ML, Morris R, Whitworth JA. Measuring blood pressure in pregnant women: a comparison of direct and indirect methods. Am J Obstet Gynaecol. 1994; 171: 661 -7.
3. Brown MA, Buddle ML, Farrell TJ, Davis G, Jones M. Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V. Lancet. 1998;352:771-781.
4. De Swiet M, Shennan A. Blood pressure measurement in pregnancy. Br J Obstet Gynaecol. 1996; 103: 862-863.
5. Shennan A, Gupta M, Halligan A, Taylor D, De Swiet M. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet. 1996; 347: 139-142.
6. Brown MA, Buddle ML. What's in a name? Problems with the classification of hypertension in pregnancy. J Hypertension. 1997; 15: 1049-54.
7. Newman RB, Eddy GL. Association of eclampsia and hydatidiform mole: case report and review of the literature. Obstet Gynecol Survey. 1988; 43: 185- 190.
8. Brown MA. The physiology of pre-eclampsia. Clin Exper Pharmacol Physiol. 1995; 22:781 -91
9. Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993; 341: 1447-1450.
10. Kuo VS, Koumantakis G, Gallery EDM. Proteinuria and its assessment in normal and hypertensive pregnancy. Am J Obstet Gynecol. 1992; 167: 723-728.
11. Brown MA, Buddle ML. Inadequacy of dipstick proteinuria in hypertensive pregnancy. Aust NZ J Obstet Gynaecol. 1995; 35: 366-369.
12. Saudan PJ, Brown MA, Farrell T, Shaw L. Improved methods of assessing proteinuria in hypertensive pregnancy. Br J Obstet Gynaecol. 1997; 104: 1159-64.
13. Saudan PJ, Brown MA, Buddle ML, Jones M. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol. In press.
14. Brown MA, Whitworth JA. Hypertension in Pregnancy, in. Bennett WM, McCarron DA (eds). Contemporary Issues in Nephrology. Pharmacology and management of hypertension. Churchill Livingstone. New York. 1994; 28: 89-116.
15. Steyn DW, Odendaal HJ. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet 1997: 350: 1267-71
16. Crowther CA, Bouwmeester AM, Ashurst HM. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol. 1992; 99: 13- 17.
17. Mathews DD, Patel IR, Sengupta SM. Out-patient management of toxaemia. J Obstet Gynaecol Br Common 1971; 78: 610-619.
18. Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe pre-eclampsia. Am J Obstet Gynecol. 1996; 175: 1313-1316.
19. Pertuiset N, Grunfeld JP. Acute renal failure in pregnancy. in:Lindheimer MD, Davison JM (eds). Renal disease in pregnancy. Bailliere's Clinical Obstetrics and Gynecology. Bailliere Tindall. London. 1994; 8: 333-51.
20. Brown MA, Buddle ML. Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features. Med J Aust. 1996; 165: 360-365.
21. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet. 1995; 345: 1455-1462
22. Lucas M, Leveno K, Cunningham G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333: 201-205.
23. Roberts J. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333: 250-251
24. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Anticonvulsants for women with severe pre-eclampsia. Cochrane Database of Systematic Reviews. 1/8/96.
25. Mittendorf R. Covert R, Boman J, Khoshnood B, Lee K-S. Sieger M. Tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet. 1997; 350: 1517-1518.
26. Brown MA, Buddle ML. Is it safe to withhold convulsion prophylaxis in pre-eclamptic women without neurological features? Hypertens Pregnancy. 1998; 17: 13-21.
27. Douglas K, Redman C. Eclampsia in the United Kingdom. Br Med J. 1994; 309: 1395-1399.
28. Ihle BU, Long P, Oats J. Early onset pre-eclampsia: recognition of underlying renal disease. Br Med J. 1987; 294: 79-81.
29. Reiter L, Brown MA, Whitworth JA. Hypertension in pregnancy: the incidence of underlying renal disease and essential hypertension. Am J Kidney Dis. 1994: 24: 883-887.
30. Packham DK, North RA, Fairley KF, Kloss M. Whitworth JA, Kincaid-Smith P. Primary glomerulonephritis and pregnancy. Quarterly Journal of Medicine 1989; 7:537-549.
31. Jungers P, Chauveau D. Pregnancy in renal disease. Kidney Int. 1997; 52: 871-885.
32. Pollock CA, Gallery EDM, Gyory AZ. Hypertension due to renal artery stenosis in pregnancy - the use of angioplasty. Aust NZ J Obstet Gynaecol. 1990; 30: 265-268.
33. Oliver MD, Brownjohn JAM, Vinall PS. Medical management of phaeochromocytoma in pregnancy. Aust NZ J Obstet Gynaecol. 1990; 30: 268-271.
34. Hammond TJ, Buchanan JD, Thatcher R, Scoggins BA, Whitworth JA. Conn's syndrome in pregnancy. Australian and New Zealand Journal of Medicine 1989; 12:537-539.
35. Gallery EDM. Chronic and secondary hypertension, in: Handbook of Hypertension. Volume 10: Hypertension in Pregnancy. PC Rubin (ed). Elsevier Science. 1988: 202-222
36. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 1990; 163: 1691 - 1712.
37. Australasian Society for the Study of Hypertension in Pregnancy. Management of Hypertension in Pregnancy: Consensus Summary. Med J Aust. 1993; 158: 700-702.
38. Hanssens M, Keirse MJNC, Vankelecom F, Van Assche A. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991; 78: 128-135.
39. Are ACE inhibitors safe in pregnancy. Lancet. 1989; 2: 482-483.
40. Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. Br Med J. 1990: 301: 587-589.
41. Montan S, Ingemarsson I, Marsal K, Sjoberg N-O. Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics Br Med J. 1992; 304: 946-949.
42. Gallery EDM, Saunders DM, Hunyor SN, Gyory AZ. Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy. Br Med J. 1979; 1: 1591-1594.
43. Pickering TG. Blood pressure measurement and detection of hypertension. Lancet. 1994; 344: 31-35.
44. CLASP Collaborative Group. CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994; 343: 619-629.
45. Caritis S, Sibai B, Hauth JC et al. Low dose aspirin to prevent pre-eclampsia in women at high risk. N Engl J Med. 1998; 338: 701-705.
46. Brennecke S, Brown M, Crowther C, et al. Aspirin and prevention of pre-eclampsia. Aust NZ J Obsetet Gynaecol. 1995; 35: 38-41.
47. Levine RJ, Hauth JC, Curet LB et al. Trial of calcium to prevent pre-eclampsia. N Engl J Med. 1997; 337: 69-76.